Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports
Abstract Background Sugammadex is a modified gamma-cyclodextrin that acts by selectively encapsulating free amino-steroidal neuromuscular relaxants. Several case reports have been published on the use of sugammadex in patients with neuromuscular disorders that include neuromuscular junction diseases...
Main Authors: | Usha Gurunathan, Shakeel Meeran Kunju, Lisa May Lin Stanton |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Anesthesiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12871-019-0887-3 |
Similar Items
-
Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01) -
The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
by: Soon Ho Cheong, et al.
Published: (2015-12-01) -
Myasthenia gravis and sugammadex: A case report and review of the literature
by: Sujana Dontukurthy, et al.
Published: (2020-01-01) -
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01) -
Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
by: Yong Beom Kim, et al.
Published: (2020-06-01)